BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32019947)

  • 1. Compatibility of aztreonam in four commercial peritoneal dialysis fluids.
    Tobudic S; Prager I; Kussmann M; Obermüller M; Ursli M; Zeitlinger M; Wiesholzer M; Burgmann H; Poeppl W; Reznicek G
    Sci Rep; 2020 Feb; 10(1):1788. PubMed ID: 32019947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility of fosfomycin with different commercial peritoneal dialysis solutions.
    Kussmann M; Baumann A; Hauer S; Pichler P; Zeitlinger M; Wiesholzer M; Burgmann H; Poeppl W; Reznicek G
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2237-2242. PubMed ID: 28685187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compatibility of Meropenem with Different Commercial Peritoneal Dialysis Solutions.
    Wiesholzer M; Winter A; Kussmann M; Zeitlinger M; Pichler P; Burgmann H; Reznicek G; Poeppl W
    Perit Dial Int; 2017 1-2; 37(1):51-55. PubMed ID: 27605684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions.
    Kussmann M; Ferth A; Obermüller M; Pichler P; Zeitlinger M; Wiesholzer M; Burgmann H; Poeppl W; Reznicek G
    Sci Rep; 2019 Apr; 9(1):6512. PubMed ID: 31019280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa.
    Kussmann M; Hauer S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1091-1098. PubMed ID: 29546637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability and Compatibility of Antibiotics in Peritoneal Dialysis Solutions Applied to Automated Peritoneal Dialysis in The Pediatric Population.
    Deslandes G; Grégoire M; Bouquié R; Le Marec A; Allard S; Dailly E; Pineau A; Allain-Launay E; Jolliet P; Roussey G; Navas D
    Perit Dial Int; 2016 11-12; 36(6):676-679. PubMed ID: 27147292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of linezolid with commercial peritoneal dialysis solutions.
    Poeppl W; Rainer-Harbach E; Kussmann M; Pichler P; Zeitlinger M; Wiesholzer M; Burgmann H; Reznicek G
    Am J Health Syst Pharm; 2018 Oct; 75(19):1467-1477. PubMed ID: 30257843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli.
    Kussmann M; Schuster L; Wrenger S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M
    Perit Dial Int; 2016 11-12; 36(6):662-668. PubMed ID: 27680756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridine levels in ceftazidime - peritoneal dialysis admixtures stored at body temperature.
    Nguyen TT; Harmanjeet H; Wanandy T; Castelino RL; Sud K; Jose MD; Peterson GM; Zaidi STR; Patel RP
    Perit Dial Int; 2020 Mar; 40(2):171-178. PubMed ID: 32063195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis.
    Kussmann M; Schuster L; Zeitlinger M; Pichler P; Reznicek G; Wiesholzer M; Burgmann H; Poeppl W
    Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2257-63. PubMed ID: 26337433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic behavior of intraperitoneal teicoplanin during treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
    Finch RC; Holliday AP; Innes A; Burden RP; Morgan AG; Shaw PN; Harding I; Wale MC
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1971-2. PubMed ID: 8843320
    [No Abstract]   [Full Text] [Related]  

  • 12. Stability of Antibiotics for Intraperitoneal Administration in Extraneal 7.5% Icodextrin Peritoneal Dialysis Bags (STAB Study).
    Ranganathan D; Naicker S; Wallis SC; Lipman J; Ratanjee SK; Roberts JA
    Perit Dial Int; 2016; 36(4):421-6. PubMed ID: 26493753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Culture-directed antibiotics in peritoneal dialysis solutions: a systematic review focused on stability and compatibility.
    Ling CW; Sud K; Patel R; Peterson G; Wanandy T; Yeoh SF; Van C; Castelino R
    J Nephrol; 2023 Sep; 36(7):1841-1859. PubMed ID: 37548827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro antimicrobial activity of vancomycin, teicoplanin, daptomycin and ceftobiprole in four different peritoneal dialysis fluids.
    Tobudic S; Poeppl W; Kratzer C; Vychytil A; Burgmann H
    Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1327-34. PubMed ID: 22009289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of Meropenem and Piperacillin/Tazobactam with Heparin in Various Peritoneal Dialysis Solutions.
    Mendes K; Harmanjeet H; Sedeeq M; Modi A; Wanandy T; Zaidi STR; Ming LC; Castelino RL; Sud K; Peterson GM; Patel RP
    Perit Dial Int; 2018; 38(6):430-440. PubMed ID: 29991562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Pyridine Generation in Ceftazidime-Icodextrin Admixtures Used to Treat Peritoneal Dialysis-associated Peritonitis.
    Kaur H; Harmanjeet H; Wanandy T; Castelino RL; Sud K; Jose MD; Peterson GM; Patel RP
    Clin Ther; 2019 Nov; 41(11):2446-2451. PubMed ID: 31575441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of ceftolozane and tazobactam in different peritoneal dialysis solutions.
    Harmanjeet H; Jani H; Zaidi STR; Wanandy T; Castelino RL; Sud K; Peterson GM; Patel RP
    Perit Dial Int; 2020 Sep; 40(5):470-476. PubMed ID: 32052692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of drug additives in peritoneal dialysis solutions in a new container.
    Voges M; Faict D; Lechien G; Taminne M
    Perit Dial Int; 2004; 24(6):590-5. PubMed ID: 15559489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for peritoneal dialysis-associated peritonitis.
    Ballinger AE; Palmer SC; Wiggins KJ; Craig JC; Johnson DW; Cross NB; Strippoli GF
    Cochrane Database Syst Rev; 2014 Apr; (4):CD005284. PubMed ID: 24771351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of tobramycin and ceftazidime in icodextrin peritoneal dialysis solution.
    Pallotta KE; Elwell RJ; Nornoo AO; Manley HJ
    Perit Dial Int; 2009; 29(1):52-7. PubMed ID: 19164253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.